Omnicell Inc (OMCL) News

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

Omnicell delivers strong fourth quarter financial results Results exceed previously issued full year guidance for bookings, total revenues, and...

Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the...

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 43rd Annual J.P...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Omnicell Announces OmniSphere

Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices...

Form 8-K - Current report

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th...

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities